NasdaqGS - Nasdaq Real Time Price
USD
Anavex Life Sciences Corp. (AVXL)
1.1500
+0.0400
(+3.60%)
As of 2:37:48 PM EST. Market Open.
Trade AVXL on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreInsider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
|
Purchases
|
0 | 0 |
|
Sales
|
-- | 0 |
|
Net Shares Purchased (Sold)
|
0 | 0 |
|
Total Insider Shares Held
|
1.58M | -- |
|
% Net Shares Purchased (Sold)
|
-- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -13,100,434 |
| % Change in Institutional Shares Held | -35.21% |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| MISSLING CHRISTOPHER U Chief Executive Officer |
Conversion of Exercise of derivative security at price 5.04 per share. | Direct | 945,000 | Sep 11, 2025 |
| THOMAS STEFFEN PHD Director |
Conversion of Exercise of derivative security at price 1.76 per share. | Direct | 88,000 | Jun 5, 2025 |
| MISSLING CHRISTOPHER U Chief Executive Officer |
Conversion of Exercise of derivative security at price 0.92 per share. | Direct | 460,000 | Mar 24, 2025 |
